Skip to main content

Loading market data...

ICUI

ICU Medical, Inc.

NASDAQ • United states

$161.96

+$0.88

(+0.55%)

Source: Yahoo Finance · Quote time Oct 21, 2026 13:50 GMT+0000

Management
Credibility
Score

ICU Medical, Inc. (ICUI)

Unavailable

Quotes may be delayed

$4.05B

Market Cap

43,140

Volume

134.6

P/E Ratio

Unavailable

Div Yield

ICU Medical, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 951 CALLE AMANECER, SAN CLEMENTE, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ICU Medical, Inc..

13 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in ICU Medical, Inc..

6 Aug 2026

ICU Medical, Inc. filed Form 10-Q

ICU Medical, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

6 Aug 2026

ICU Medical, Inc. reported Operating or financial results

ICU Medical, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

18 May 2026

ICU Medical, Inc. reported A charter or bylaws change

ICU Medical, Inc. filed an 8-K covering a charter or bylaws change, shareholder voting results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$208.78M

Total assets (USD)$3.97B

Shareholders' equity (USD)$2.15B

Long-term debt (USD)$1.21B

Debt due within a year (USD)$18.75M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$551.68M	$39.13M	$19.09M	$0.76	10-Q · 6 Aug 2026
Q1 2026	$530.23M	$13.58M	$30.13M	$1.20	10-Q · 7 May 2026
Q4 2025	$540.70M	$5.64M	−$15.73M	Unavailable	10-K · 19 Feb 2026
Q3 2025	$536.99M	$13.72M	−$3.40M	−$0.14	10-Q · 6 Nov 2025
Q2 2025	$548.87M	$10.59M	$35.34M	$1.43	10-Q · 7 Aug 2025
Q1 2025	$604.70M	$12.89M	−$15.48M	−$0.63	10-Q · 8 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $195.50

20.7% upside potential

📈

Strong Buy

Unavailable

👍

Buy

4

⏸️

Hold

0

📉

Sell

0

4 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 13:51 UTC Targets range 187.00–200.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

3

Sep 2026

Sanzone Virginia Ruth

VP, General Counsel

Open-market sale

$168.69 per share

4,856 shares

1

Sep 2026

Bonnell Brian Michael

Chief Financial Officer

Open-market sale

$175.00 per share

6,381 shares

31

Aug 2026

Bonnell Brian Michael

Chief Financial Officer

Open-market sale

$172.79 per share

9,307 shares

13

Aug 2026

Woolson Daniel

VP, GM-Infusion Capital

Open-market sale

$181.33 per share

5,417 shares

12

Aug 2026

Sousa Ben

Chief Information Officer

Open-market sale

$178.32 per share

2,250 shares

11

Aug 2026

Voigtlander Christian B.

Chief Operating Officer

Open-market sale

$182.93 per share

8,929 shares

11

Aug 2026

FINNEY ELISHA W

Director

Open-market sale

$182.48 per share

378 shares

22

May 2026

Woolson Daniel

President

Open-market sale

$132.21 per share

2,123 shares

Top Shareholders

Blackrock, Inc.

3,753,409 shares

4.021% change

6/30/2026

Jupiter Topco Llc

2,781,620 shares

New% change

6/30/2026

Vanguard Group Inc

2,714,746 shares

3.419% change

12/31/2025

Janus Henderson Group Ltd.

2,676,012 shares

3.852% change

3/31/2026

Vanguard Portfolio Management Llc

1,470,583 shares

2.289% change

6/30/2026

Fuller & Thaler Asset Management, Inc.

1,298,127 shares

6.357% change

6/30/2026

Vanguard Capital Management Llc

1,123,237 shares

1.022% change

6/30/2026

Dimensional Fund Advisors Lp

1,053,476 shares

7.082% change

6/30/2026

State Street Corp

1,024,369 shares

5.817% change

6/30/2026

Schroder Investment Management Group

739,138 shares

5.398% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 13:51 UTC· 19 hours ago

Research coverage and investment tools

ICU Medical, Inc. (ICUI) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Medical/Dental Instruments). Its last price was US$161.96 on 21 Oct 2026. That is 61% of the way from its 52-week low of US$113.37 to its 52-week high of US$192.85. Its market capitalisation was US$4.05 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$551.68M	$39.13M	$19.09M	$0.76	42.6%	7.1%	$61.64M	10-Q · 6 Aug 2026 (opens in a new tab)
Q1 2026	$530.23M	$13.58M	$30.13M	$1.20	38.9%	2.6%	$27.61M	10-Q · 7 May 2026 (opens in a new tab)
Q4 2025	$540.70M	$5.64M	−$15.73M	Unavailable	37.5%	1.0%	$35.95M	10-K · 19 Feb 2026 (opens in a new tab)
Q3 2025	$536.99M	$13.72M	−$3.40M	−$0.14	37.4%	2.6%	$27.63M	10-Q · 6 Nov 2025 (opens in a new tab)
Q2 2025	$548.87M	$10.59M	$35.34M	$1.43	37.9%	1.9%	−$8.49M	10-Q · 7 Aug 2025 (opens in a new tab)
Q1 2025	$604.70M	$12.89M	−$15.48M	−$0.63	34.7%	2.1%	$36.71M	10-Q · 8 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/6/2026	$2.01	$1.49	+34.9%
Mar 2026	5/7/2026	$1.55	$1.33	+16.5%
Dec 2025	2/19/2026	$1.48	$1.32	+12.1%
Sep 2025	11/6/2025	$1.66	$1.13	+46.9%

Cash and equivalents: $208.78M
Total assets: $3.97B
Shareholders' equity: $2.15B
Long-term debt: $1.21B
Debt due within a year: $18.75M

SCHEDULE 13G/A · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in ICU Medical, Inc..
SCHEDULE 13G/A · 13 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in ICU Medical, Inc..
10-Q · 6 Aug 2026

ICU Medical, Inc. filed Form 10-Q (opens in a new tab)

ICU Medical, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 6 Aug 2026

ICU Medical, Inc. reported Operating or financial results (opens in a new tab)

ICU Medical, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 18 May 2026

ICU Medical, Inc. reported A charter or bylaws change (opens in a new tab)

ICU Medical, Inc. filed an 8-K covering a charter or bylaws change, shareholder voting results, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Sanzone Virginia Ruth VP, General Counsel	3 Sep 2026	Open-market sale (S)	−4,856	$168.69	Form 4 (opens in a new tab)
Bonnell Brian Michael Chief Financial Officer	1 Sep 2026	Open-market sale (S)	−6,381	$175.00	Form 4 (opens in a new tab)
Bonnell Brian Michael Chief Financial Officer	31 Aug 2026	Open-market sale (S)	−9,307	$172.79	Form 4 (opens in a new tab)
Woolson Daniel VP, GM-Infusion Capital	13 Aug 2026	Open-market sale (S)	−5,417	$181.33	Form 4 (opens in a new tab)
Sousa Ben Chief Information Officer	12 Aug 2026	Open-market sale (S)	−2,250	$178.32	Form 4 (opens in a new tab)
Voigtlander Christian B. Chief Operating Officer	11 Aug 2026	Open-market sale (S)	−8,929	$182.93	Form 4 (opens in a new tab)
FINNEY ELISHA W Director	11 Aug 2026	Open-market sale (S)	−378	$182.48	Form 4 (opens in a new tab)
Woolson Daniel President	22 May 2026	Open-market sale (S)	−2,123	$132.21	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	3,753,409	4.021%
Jupiter Topco Llc	6/30/2026	2,781,620	New
Vanguard Group Inc	12/31/2025	2,714,746	3.419%
Janus Henderson Group Ltd.	3/31/2026	2,676,012	3.852%
Vanguard Portfolio Management Llc	6/30/2026	1,470,583	2.289%
Fuller & Thaler Asset Management, Inc.	6/30/2026	1,298,127	6.357%
Vanguard Capital Management Llc	6/30/2026	1,123,237	1.022%
Dimensional Fund Advisors Lp	6/30/2026	1,053,476	7.082%
State Street Corp	6/30/2026	1,024,369	5.817%
Schroder Investment Management Group	6/30/2026	739,138	5.398%

Previous close: 161.08 USD
Day range: 159.52 – 161.96 USD
52-week range: 113.37 – 192.85 USD
Volume: 43,140
Market cap: $4.05B
Average volume: 234,065
P/E ratio: 134.6
EPS (FY 2025, diluted): 0.03 USD
Shares outstanding: 25.01M
Beta (5Y monthly): 0.89

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 13:50 UTC· 19 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:11 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for ICUI yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.